Advertisement
Short report
Type 1 diabetes mellitus (T1DM) is one of the most common pediatric diseases and its incidence is rising in many countries. Recently, it has been shown that metabolites other than glucose play an important rol...
Diabetology & Metabolic Syndrome 2017 9:48
Published on: 26 June 2017
Research
Type 2 diabetes is a major healthcare problem. Glucose-, lipid-, and blood pressure-lowering strategies decrease the risk of micro- and macrovascular complications. However, a substantial residual risk remains...
Diabetology & Metabolic Syndrome 2017 9:47
Published on: 19 June 2017
Research
Type 2 diabetes mellitus (T2DM) is a complex disease, particularly in a continental country like Brazil. We attempted to understand and evaluate the perceptions and routines of Brazilians with T2DM and physici...
Diabetology & Metabolic Syndrome 2017 9:46
Published on: 15 June 2017
Research
Ten to forty percent of nonalcoholic steatohepatitis (NASH) and HCV-related chronic liver disease (CLD-C) patients have antinuclear antibodies (ANAs). However, the relationship between autoimmune response and ...
Diabetology & Metabolic Syndrome 2017 9:45
Published on: 13 June 2017
Review
The prevalence of obesity increases worldwide. Treating obesity and its associated health problems has a significant economic impact on health care systems. The unsatisfactory long-term outcomes observed in th...
Diabetology & Metabolic Syndrome 2017 9:44
Published on: 31 May 2017
Research
Type 2 diabetes (T2D) is associated with reduced numbers and impaired function of circulating angiogenic cells (CAC) which contributes to the progression of atherosclerosis and microvascular disease. Previous ...
Diabetology & Metabolic Syndrome 2017 9:43
Published on: 31 May 2017
Research
The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biom...
Diabetology & Metabolic Syndrome 2017 9:42
Published on: 30 May 2017
Research
To evaluate the effect of different anti-diabetic treatment strategy on oxidative stress markers in patients with type 2 diabetes mellitus (T2DM).
Diabetology & Metabolic Syndrome 2017 9:27
Published on: 25 May 2017
Research
The aim of this study was to investigate plasma levels of sST2 and sCD163 to determine whether they at an early stage could predict development of diabetic nephropathy and/or diabetic retinopathy in patients a...
Diabetology & Metabolic Syndrome 2017 9:41
Published on: 25 May 2017
Research
The metabolic syndrome (MetS) and its components are well-established risk factors for cardiovascular diseases (CVD). It is inconclusive whether MetS and MetS score are associated with electrocardiographic mar...
Diabetology & Metabolic Syndrome 2017 9:40
Published on: 22 May 2017
Research
Nesfatin-1, originating from its precursor protein called nucleobindin 2 (NUCB2), plays an important role in glucose metabolism and diabetes. The aim of this study is to examine the association of the c.1012C>...
Diabetology & Metabolic Syndrome 2017 9:39
Published on: 19 May 2017
Research
There is a substantial reduction in cardiovascular related morbidity and mortality in the general population attributed to improved treatment of cardiac risk factors and disease, the same magnitude of benefit ...
Diabetology & Metabolic Syndrome 2017 9:38
Published on: 19 May 2017
Research
The primary aim of the disease management program (DMP) for patients with diabetes mellitus type 2 is to improve the quality of health care and the treatment process. 12 years after its introduction in Germany...
Diabetology & Metabolic Syndrome 2017 9:37
Published on: 18 May 2017
Review
Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of ins...
Diabetology & Metabolic Syndrome 2017 9:36
Published on: 15 May 2017
Research
Several antidiabetic therapies affect bone metabolism. Sulfonylureas have the lowest impact on bone among oral antidiabetics. The objective of this study is to compare the effects of vildagliptin and gliclazid...
Diabetology & Metabolic Syndrome 2017 9:35
Published on: 15 May 2017
Research
Obesity’s increasing follows decreased perception of weight status in obese persons, mainly female, undergoing age-related changes.
Diabetology & Metabolic Syndrome 2017 9:34
Published on: 12 May 2017
Research
Obesity may have a role in the development of gestational diabetes mellitus (GDM). Single-nucleotide-polymorphisms (SNPs) of the FTO (fat mass and obesity associated) gene have been associated with obesity. Th...
Diabetology & Metabolic Syndrome 2017 9:32
Published on: 12 May 2017
Research
Cardiovascular disease constitutes a major challenge for the health of community-dwelling population, it is essential to delay the development of atherosclerosis. However, long-term prospective studies analyzi...
Diabetology & Metabolic Syndrome 2017 9:33
Published on: 12 May 2017
Research
The study assessed mRNA expression of podocyte-associated molecules in urinary sediments of patients with type 2 diabetes mellitus (DM) in relation to urinary podocytes, biomarkers of podocyte injury and of pr...
Diabetology & Metabolic Syndrome 2017 9:31
Published on: 6 May 2017
Research
There is a high hospitalization rate for diabetic patients. Since retinopathy and albuminuria are both important manifestations of microvascular disease in diabetes, our aim was to investigate the effect of re...
Diabetology & Metabolic Syndrome 2017 9:29
Published on: 3 May 2017
Research
Sixty years ago diabetes was almost non-existent in Greenland and until the beginning of this century awareness of diabetes was quite minimal. A high prevalence of undiagnosed diabetes has been reported in rep...
Diabetology & Metabolic Syndrome 2017 9:30
Published on: 3 May 2017
Research
Diabetology & Metabolic Syndrome 2017 9:28
Published on: 2 May 2017
Research
Dipeptidyl peptidase-4 (DDP4) is an enzyme responsible for glucagon-like peptide-1 inactivation and plays an important role in glucose metabolism.
Diabetology & Metabolic Syndrome 2017 9:26
Published on: 24 April 2017
Review
Although patients with diabetes have 2 to 4 times increased risk of cardiovascular morbidity and mortality than individuals without diabetes, recent studies indicate that a significant part of patients are in ...
Diabetology & Metabolic Syndrome 2017 9:25
Published on: 20 April 2017
The Erratum to this article has been published in Diabetology & Metabolic Syndrome 2017 9:70
Research
Excess weight (overweight and obesity) is the major modifiable risk factor for type 2 diabetes mellitus (T2DM) and other non-communicable diseases. However, excess weight may not be as predictive of diabetes r...
Diabetology & Metabolic Syndrome 2017 9:24
Published on: 19 April 2017
The official journal of the Brazilian Diabetes Society.
Advertisement
